2019
HIV Disease Severity Is Sensitive to Temporal Changes in Alcohol Use: A National Study of VA Patients With HIV.
Williams EC, McGinnis KA, Tate JP, Matson TE, Rubinsky AD, Bobb JF, Lapham GT, Edelman EJ, Catz SL, Satre DD, Bryant KJ, Marshall BDL, Kraemer KL, Bensley KM, Richards JE, Skanderson M, Justice AC, Fiellin DA, Bradley KA. HIV Disease Severity Is Sensitive to Temporal Changes in Alcohol Use: A National Study of VA Patients With HIV. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2019, 81: 448-455. PMID: 30973541, PMCID: PMC6594884, DOI: 10.1097/qai.0000000000002049.Peer-Reviewed Original ResearchConceptsVACS Index 2.0HIV disease severityVeterans Aging Cohort StudyAlcohol useDisease severityLow-level alcohol useNational Veterans Health AdministrationChange scoresAging Cohort StudyVeterans Health AdministrationAUDIT-C screensAUDIT-CsCohort studyHIV severityVA patientsHealth AdministrationSeverity measuresSeverityHIVPWHMultiple mechanismsNational studyScoresNational sampleDays
2013
Measuring alcohol consumption using Timeline Followback in non-treatment-seeking medical clinic patients with and without HIV infection: 7-, 14-, or 30-day recall.
Fiellin DA, Mcginnis KA, Maisto SA, Justice AC, Bryant K. Measuring alcohol consumption using Timeline Followback in non-treatment-seeking medical clinic patients with and without HIV infection: 7-, 14-, or 30-day recall. Journal Of Studies On Alcohol And Drugs 2013, 74: 500-4. PMID: 23490581, PMCID: PMC3602364, DOI: 10.15288/jsad.2013.74.500.Peer-Reviewed Original ResearchConceptsTimeline FollowbackAlcohol consumptionHeavy episodic drinkingHIV infectionHIV statusEpisodic drinkingPercent agreementInfectious disease clinicMedical clinic patientsKappa statisticsUninfected menDisease clinicSpearman correlation coefficientClinic patientsClinic subjectsOptimal time windowHIVMedical careMedical clinicsPatientsGold standardClinicInfectionDrinkingDays
2011
Rural Residence and Adoption of a Novel HIV Therapy in a National, Equal-Access Healthcare System
Ohl M, Lund B, Belperio PS, Goetz MB, Rimland D, Richardson K, Justice A, Perencevich E, Vaughan-Sarrazin M. Rural Residence and Adoption of a Novel HIV Therapy in a National, Equal-Access Healthcare System. AIDS And Behavior 2011, 17: 250-259. PMID: 22205324, PMCID: PMC5009625, DOI: 10.1007/s10461-011-0107-8.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedCD4 Lymphocyte CountChildChild, PreschoolDelivery of Health CareDiffusion of InnovationFemaleHealth Services AccessibilityHealthcare DisparitiesHIV InfectionsHIV Integrase InhibitorsHumansInfantInfant, NewbornMaleMiddle AgedMultivariate AnalysisOdds RatioPatient Acceptance of Health CarePyrrolidinonesRaltegravir PotassiumResidence CharacteristicsRetrospective StudiesRural Health ServicesRural PopulationSurveys and QuestionnairesUnited StatesUnited States Department of Veterans AffairsUrban PopulationVeteransViral LoadYoung AdultConceptsHIV therapyEqual access healthcare systemNovel HIV therapiesRetrospective cohort studyFirst HIV integrase inhibitorRural-urban variationRaltegravir therapyCohort studyPatient characteristicsMultivariable analysisHIV integrase inhibitorsClinical indicationsRural residenceFDA approvalTherapyIntegrase inhibitorsUrban residenceRural personsHealthcare systemRaltegravirUrban personsDaysRural areasHIVResidence
2009
Measuring Persistence to Oral Hypoglycemic Agents in Type 2 Diabetic Veterans
Kim N, Agostini J, Justice A. Measuring Persistence to Oral Hypoglycemic Agents in Type 2 Diabetic Veterans. Journal Of Pharmacy Technology 2009, 25: 223-229. PMID: 21779543, PMCID: PMC3139220, DOI: 10.1177/875512250902500402.Peer-Reviewed Original ResearchOral hypoglycemic agentsHypoglycemic agentsDiabetic veteransTotal daysStudy entryMedian persistenceKappa agreement statisticsContinuous refillMultiple comorbiditiesMost patientsMedian ageDiabetes controlMedication adherenceInclusion criteriaEligible veteransPoor persistenceSubstantial proportionClinical applicationVeteransPatientsFirst yearAgreement statisticsDaysPrescriptionContinuous fill